Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (241-250 of 386) with videos related to

Pageof 39
Sort By:
Molecular Cancer Therapeutics|February 20, 2007
Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactionsRoberto R Rosato, Jorge A Almenara, Sarah S Kolla, et al.
Blood|December 15, 2010
Disruption of Src function potentiates Chk1-inhibitor-induced apoptosis in human multiple myeloma cells in vitro and in vivoYun Dai, Shuang Chen, Rena Shah, et al.
Advances in Cancer Research|March 29, 2023
The epigenetic regulation of cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrenceChristiana O Appiah, Manjulata Singh, Lauren May, et al.
Cancer Biology & Therapy|August 13, 2002
Pharmocologic inhibitors of the mitogen activated protein kinase cascade have the potential to interact with ionizing radiation exposure to induce cell death in carcinoma cells by multiple mechanismsLiang Qiao, Adly Yacoub, Robert McKinstry, et al.
Biochemical Pharmacology|October 7, 2005
Inhibition of insulin/IGF-1 receptor signaling enhances bile acid toxicity in primary hepatocytesPaul Dent, Song Iy Han, Clint Mitchell, et al.
Biometrical Journal. Biometrische Zeitschrift|May 18, 2016
Nonlinear response surface in the study of interaction analysis of three combination drugsWen Wan, Xin-Yan Pei, Steven Grant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2023
Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist VenetoclaxToshihisa Satta, Lin Li, Sri Lakshmi Chalasani, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53Liang Qiao, Robert McKinstry, Seema Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemiaLouise H Cragg, Michael Andreeff, Eric Feldman, et al.
British Journal of Haematology|August 13, 2010
The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cellsYun Dai, Monica L Guzman, Shuang Chen, et al.
Pageof 39

Showing results (241-250 of 386) with videos related to

Sort By:
Pageof 39
Molecular Cancer Therapeutics|February 20, 2007
Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactionsRoberto R Rosato, Jorge A Almenara, Sarah S Kolla, et al.
Blood|December 15, 2010
Disruption of Src function potentiates Chk1-inhibitor-induced apoptosis in human multiple myeloma cells in vitro and in vivoYun Dai, Shuang Chen, Rena Shah, et al.
Advances in Cancer Research|March 29, 2023
The epigenetic regulation of cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrenceChristiana O Appiah, Manjulata Singh, Lauren May, et al.
Cancer Biology & Therapy|August 13, 2002
Pharmocologic inhibitors of the mitogen activated protein kinase cascade have the potential to interact with ionizing radiation exposure to induce cell death in carcinoma cells by multiple mechanismsLiang Qiao, Adly Yacoub, Robert McKinstry, et al.
Biochemical Pharmacology|October 7, 2005
Inhibition of insulin/IGF-1 receptor signaling enhances bile acid toxicity in primary hepatocytesPaul Dent, Song Iy Han, Clint Mitchell, et al.
Biometrical Journal. Biometrische Zeitschrift|May 18, 2016
Nonlinear response surface in the study of interaction analysis of three combination drugsWen Wan, Xin-Yan Pei, Steven Grant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2023
Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist VenetoclaxToshihisa Satta, Lin Li, Sri Lakshmi Chalasani, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53Liang Qiao, Robert McKinstry, Seema Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemiaLouise H Cragg, Michael Andreeff, Eric Feldman, et al.
British Journal of Haematology|August 13, 2010
The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cellsYun Dai, Monica L Guzman, Shuang Chen, et al.
Pageof 39